#MEAction UK response to NICE 2017
UK clinical guidelines are written by a body called the National Institute for Health and Clinical Excellence (NICE). The current guidelines were last revised in 2007 and contain recommendations that people with ME consider unsuitable and potentially harmful. These guidelines also impact how ME is perceived in other countries, so it is not an isolated UK problem.
It is clear to us that the 2007 guidelines require an update, so we were dismayed to hear that NICE had looked at the evidence and is inclined to think no update is required. In July 2017 stakeholder organisations were given two weeks to respond to the proposal not to update (link https://www.nice.org.uk/guidance/cg53/documents/surveillance-review-proposal). Two weeks to agree and write an effective argument, at a time when those with milder ME were flying off on holiday. For us, as a grassroots network of people with ME, this timeframe seemed like an almost insurmountable barrier to full participation.
However, with a team of about fifteen people we rallied together to team write. We got advice on wording from experts and references from the wider online community. We busied ourselves with writing and commenting (up to the limit of how busy a group of mostly people with ME can be!). What has resulted from our team effort is an unexpectedly comprehensive explanation of our reasons for disagreeing with the no update proposal. We hope it will also be useful for you all as a general document about the state of play for ME UK politics and research in 2017.
This is our response to NICE: PDF / HTML
In August, we shared with you that we and six other ME/CFS organizations had submitted a proposal to the National Center of Health Statistics (NCHS) to fix the coding of ME/CFS in the US International Classification of Diseases (ICD-10-CM). Today, we are writing with an update on that proposal and asking that you sign the